论文部分内容阅读
目的：观察ＷＨＯ全球哮喘防治策略方案对本地１００例小儿哮喘的效果。方法：对１００例哮喘患儿使用持续倍氯米松及间断沙丁胺醇吸入治疗，峰流速仪肺功能监测，检测及避免触发因素，家庭教育管理等综合疗法，跟踪观察６～１２个月。结果：总临床控制率为３８％，显效率３９％，有效率１６％，无效率７％，总有效率为９３％；有９０％的患儿治疗６个月后最大呼气流速（ＰＥＦＲ）值大于９０％；急诊就诊率从治疗前的９８％，降至治疗期间２３％、治疗６个月后７％；住院率从治疗前的２７％，降到治疗期间５％、治疗６个月后２％；治疗期间未发现明显的不良反应。结论：ＷＨＯ全球哮喘防治策略方案近期临床疗效满意。
OBJECTIVE: To observe the effect of the WHO Global Strategy for Asthma Control on 100 children with local asthma. Methods: 100 children with asthma were treated with continuous inhalation of beclometasone and intermittent salbutamol, pulmonary function monitoring of peak velocity meter, detection and avoid triggering factors, family education management and other comprehensive therapies, followed up for 6 to 12 months. Results: The total clinical control rate was 38%, the effective rate was 39%, the effective rate was 16%, the ineffective rate was 7%, the total effective rate was 93%; 90% of the children treated 6 months after the maximum expiratory flow rate (PEFR) The value of emergency attendance dropped from 98% before treatment to 23% during treatment and 7% after 6 months of treatment. The hospitalization rate dropped from 27% before treatment to 5% during treatment for 6 months After 2%; no significant adverse reactions were found during the treatment. Conclusion: WHO global strategy for asthma prevention and treatment of recent clinical results satisfactory.